GOVX Geovax Labs Inc

$GOVX so this stock is supposed to finally take off now that there is a pandemic in Russia?

$GOVX Sometime I feel like they all connected with each other. Anyway infectious disease stocks should run huge imo. Only 10M float and they need to dilute as well as plague cases in Russia. I connected the dots. Analyst pt $10 with buy rating 🦊🦊🦊🦊🦊🦊🦊🚀🚀🚀🚀

$GOVX NASDAQ delisting determination scheduled for tomorrow. Let’s hope for some good news here.

$GOVX they are monitoring the situation and will soon work towards thw cure. This can fly

$GOVX always short the splits. Its a nothing burger. Dodds retirement ponzi scheme. Dixie boii grifter 😂. Jokes on the investors.

$GOVX Labs $GOVX's Market cap: is $2.17 MILLION. An incredibly small valuation for a clinical-stage biotech with vaccine and cancer-treatment programs. IP: Over 135 granted or pending patent applications across 23 patent families, covering oncology, infectious diseases and biodefense. RSI on chart at 21: Deeply oversold territory often attract bounce traders. Oct. 6: GOVX highlighted next-generation MVA vaccine and manufacturing advances at the World Vaccine Congress Europe. Sept. 29: Highlighted likely sustained Clade Ib mpox transmission in the U.S. Sept. 21: Reported preclinical evidence of durable, single-dose protection against highly pathogenic Clade I mpox. Sept. 14: Partnered with CEPI's centralized laboratory network to support the GEO-MVA Phase 3 program. Upside? GEO-MVA's development toward Phase 3 and GeoVax's broader vaccine and oncology pipeline offer potential catalysts when clinical and commercial progress is announced.

$GOVX before this latest news, $GOVX reported preclinical data for MVA-X --- a single dose produced durable protection in animal models, including against Clade I mpox. If validated in the clinic, transitioning from a two-dose regimen toward single-dose vaccination deployment during future virus outbreaks has the potential to fundamentally change the response by public health organizations.

$GOVX If there is more bad news on this vaccine front, GOVX will probably be getting calls from the Feds and/or Big Pharma Basically, more reports of U.S. Clade Ib transmission could strengthen the long-term mpox vaccine market. GOVX's GEO-MVA’s Phase 3 is pending and is an obvious news catalyst coming. JMO